---
title: 'ç”·æ€§çš„ç¦éŸ³ï¼ageLOC R2 æ˜¯ç¬¬ä¸€æ¬¾é‡å°é«”åŠ›ã€ç²¾åŠ›ã€æ€§æ´»åŠ›çš„æŠ—è¡°è€ç‡Ÿé¤Šè£œå……é…æ–¹'
description: 'ç”·æ€§æŠ—è¡°è€å°ˆç§‘å°±æ˜¯ ageLOC R2 çš„å¼·é …ï¼'
pubDate: 2026-02-03
tags: ['å¥åº·', 'æŠ—è¡°è€', 'Nu Skin']
---

## **ç”·æ€§çš„å¤¢é­˜**

å‰å¹¾å¤©æˆ‘å•äº† ChatGPTï¼Œå•å®ƒ 30~50 æ­²æ…¢æ…¢æ­¥å…¥ä¸­å¹´çš„ç”·æ€§å¸Œæœ›æ”¹å–„ä»€éº¼ï¼Œæˆ‘è«‹å®ƒæ•´ç†ä¸€å€‹è¡¨æ ¼çµ¦æˆ‘ï¼š

é¡åˆ¥| å¸Œæœ›ç²å¾—çš„æ•ˆæœ  
---|---  
é«”èƒ½| â€¢ æå‡ç²¾åŠ›å’Œé«”åŠ›  
â€¢ å¢å¼·é‹å‹•è¡¨ç¾å’Œæ¢å¾©èƒ½åŠ›  
èº«æ| â€¢ ç¶­æŒå¥åº·é«”é‡  
â€¢ å¢åŠ æˆ–ä¿æŒè‚Œè‚‰é‡  
â€¢ æ§åˆ¶é«”è„‚ç‡  
æ€§åŠŸèƒ½| â€¢ ç¶­æŒæˆ–æé«˜æ€§æ…¾  
â€¢ æ”¹å–„å‹ƒèµ·åŠŸèƒ½  
â€¢ å¢å¼·ç”Ÿè‚²èƒ½åŠ›  
å¿ƒè¡€ç®¡| â€¢ èª¿ç¯€è¡€å£“  
â€¢ å„ªåŒ–è†½å›ºé†‡æ°´å¹³  
â€¢ å¢å¼·å¿ƒè‡ŸåŠŸèƒ½  
â€¢ é™ä½å¿ƒè‡Ÿç—…ã€ä¸­é¢¨ã€çŒæ­»é¢¨éšª  
èªçŸ¥| â€¢ æé«˜è¨˜æ†¶åŠ›å’Œé›†ä¸­åŠ›  
â€¢ å¢å¼·æ€ç¶­æ•æ·åº¦  
â€¢ é é˜²èªçŸ¥è¡°é€€  
è·çˆ¾è’™| â€¢ å„ªåŒ–ç¾é…®æ°´å¹³  
â€¢ èª¿ç¯€å£“åŠ›è·çˆ¾è’™  
å¤–è¡¨| â€¢ æ¸›å°‘çšºç´‹å’Œç´°ç´‹  
â€¢ æ”¹å–„è†šè‰²å’Œçš®è†šå½ˆæ€§  
â€¢ é é˜²æˆ–æ¸›ç·©è„«é«®  
å…ç–«| â€¢ æé«˜æŠµæŠ—åŠ›  
â€¢ æ¸›å°‘ç”Ÿç—…é »ç‡  
â€¢ é™ä½æ…¢æ€§ç™¼ç‚  
ç¡çœ | â€¢ æ”¹å–„å…¥ç¡å“è³ª  
â€¢ æé«˜ç¡çœ æ·±åº¦  
é—œç¯€| â€¢ æ¸›è¼•é—œç¯€ç–¼ç—›  
â€¢ ç¶­æŒé—œç¯€éˆæ´»æ€§  
  
çœ‹å®Œè¡¨æ ¼ï¼Œä¸æ„å¤–çš„å°±æ˜¯ç”·ç”Ÿé€šç—…ï¼Œæœ€åœ¨ä¹çš„å°±æ˜¯ã€Œå ´ä¸Šè¡¨ç¾ä¸ä½³ã€ã€ã€Œèº«é«”è®Šå·®ã€ã€ã€Œé†œè€ã€èˆ‡ã€Œç¡ä¸å¥½ã€ã€‚

ã€Œé†œè€ã€å¯ä»¥ç”¨ ageLOC Lumispa è§£æ±ºå¤–ï¼Œ

> [æ¿€æ¨å¥½ç”¨ç¬¬ä¸€åï¼ ageLOC LumiSpa æ´—è‡‰æ©Ÿï¼Œ 2 åˆ†é˜æ´—æ·¨ä¸ç·Šç¹ƒé‚„èƒ½åˆºæ¿€è† åŸè›‹ç™½å¢ç”Ÿæ˜¯çœŸçš„å—ï¼Ÿ](https://agelocked.com/%e6%bf%80%e6%8e%a8%e5%a5%bd%e7%94%a8%e7%ac%ac%e4%b8%80%e5%90%8d%ef%bc%81-ageloc-lumispa-%e6%b4%97%e8%87%89%e6%a9%9f%ef%bc%8c-2-%e5%88%86%e9%90%98%e6%b4%97%e6%b7%a8%e4%b8%8d%e7%b7%8a%e7%b9%83%e9%82%84/)

ç”·æ€§æŠ—è¡°è€å°ˆç§‘å°±æ˜¯ **ageLOC R2** çš„å¼·é …ï¼

## **èº«é«”çš„å‹•åŠ›ä¾†æº**

æƒ³åƒä½ çš„èº«é«”æ˜¯ä¸€å°è·‘è»Šã€‚

è¦è®“è·‘è»Šè·‘å¾—å¿«ï¼Œä½ éœ€è¦åŠ æ»¿æ²¹ï¼Œä¹Ÿè¦æœ‰ä¸€å°å¥½çš„å¼•æ“ã€‚

æ±½è»Šæ‰€éœ€çš„æ²¹å°±æ˜¯æˆ‘å€‘åƒçš„é£Ÿç‰©ï¼Œè€Œå¼•æ“å°±æ˜¯æˆ‘å€‘çš„ã€Œ**ç´°èƒ** ã€ã€‚

é£Ÿç‰©é€²å…¥èº«é«”å¾Œï¼Œæœƒè®Šæˆç´°èƒå¯ä»¥ç”¨çš„èƒ½é‡ï¼Œé€™æ¨£æˆ‘å€‘æ‰æœ‰åŠ›æ°£è·‘æ­¥ã€ç©è€å’Œå­¸ç¿’ã€‚

è€Œ**ç´°èƒ** æ˜¯äººé«”æœ€å°çš„ã€ŒåŒ–å·¥å» ã€ã€‚

å®ƒå€‘æœƒæŠŠé£Ÿç‰©åˆ†è§£æˆèƒ½é‡ï¼Œå¥½è®“èº«é«”çš„å…¶ä»–éƒ¨åˆ†é‹ä½œã€‚

é€™äº›èƒ½é‡å¹«åŠ©æˆ‘å€‘çš„å¿ƒè‡Ÿè·³å‹•ã€è‚ºéƒ¨å‘¼å¸ï¼Œé‚„èƒ½è®“æˆ‘å€‘å‹•è…¦æ€è€ƒã€‚

## **èº«é«”çš„ä¿®å¾©ç³»çµ±**

æˆ‘å€‘çš„èº«é«”æ¯å¤©éƒ½æœƒå—åˆ°ã€Œå£æ±è¥¿ã€çš„æ”»æ“Šï¼Œæ¯”å¦‚ä¾†è‡ªç©ºæ°£ä¸­çš„æ±¡æŸ“ç‰©ã€åƒä¸‹å»çš„åƒåœ¾é£Ÿç‰©ï¼Œç”šè‡³æ˜¯é™½å…‰ä¸­çš„ç´«å¤–ç·šã€‚

é€™äº›å£æ±è¥¿æœƒæå®³æˆ‘å€‘çš„ç´°èƒï¼Œå°±åƒè»Šå­çš„é›¶ä»¶ç£¨æä¸€æ¨£ã€‚

æŠ—æ°§åŒ–åŠ‘å°±åƒèº«é«”çš„åƒåœ¾æ¸…ç†å“¡ï¼Œå¯ä»¥å¹«åŠ©æˆ‘å€‘æŠŠç´°èƒè£¡çš„ã€Œå£æ±è¥¿ã€æ¸…ç†æ‰ã€‚

æ°´æœå’Œè”¬èœè£¡å°±æœ‰å¾ˆå¤šæŠ—æ°§åŒ–åŠ‘ï¼Œåƒæ˜¯ç¶­ç”Ÿç´ C å’Œ Eã€‚

æ°´æœå’Œè”¬èœè£¡ä¸åªæœ‰é€™äº›ï¼Œå¤§è‡ªç„¶ä¸­é‚„æœ‰å¾ˆå¤šæ›´å²å®³çš„æŠ—æ°§åŒ–åŠ‘ã€‚

## **ageLOC R2 æ˜¯æ€** éº¼å¹«åŠ©æˆ‘å€‘ï¼Ÿ

å¦‚æ–°å…¬å¸é€é ageLOC æŠ€è¡“ï¼Œæœå°‹è³‡æ–™åº«è£¡çš„æˆåˆ†å¾Œåšå‡º **ageLOC R2** ï¼

**ageLOC R2** æ‰“è‘—ã€Œå¤œå¤œæ¸…æ·¨ï¼Œå¤©å¤©å¸¶å‹ã€çš„å£è™Ÿï¼Œåˆ†ç™½å¤©èˆ‡æ™šä¸Šåƒçš„æˆåˆ†ï¼›

ã€Šæ—¥éŒ ã€‹çš„ä¸»è¦æˆåˆ†æ˜¯çŸ³æ¦´èƒå–ç‰©ï¼Œäººåƒèƒå–ç‰©ï¼Œä»¥åŠèŸ²è‰èŒçµ²é«”ï¼›

ã€Šå¤œéŒ ã€‹çš„ä¸»è¦æˆåˆ†å‰‡æ˜¯è‘¡è„ç±½èƒå–ç‰©ï¼Œç”œæ©™èƒå–ç‰©ï¼ŒåŠé’èŠ±æ¤°èœç±½èƒå–ç‰©ã€‚

## **ã€Šæ—¥éŒ ã€‹ï¼šå¤©å¤©å¸¶å‹**

è£¡é¢ 30 æ—¥ä»½ï¼Œä¸€æ¬¡ 6 é¡†ï¼Œå…± 180 é¡†ã€‚

ç™½å¤©çš„è† å›Šæ˜¯ç™½è‰²çš„ï¼Œè¿‘ä¸€é»èæœ‰æ·¡æ·¡èŸ²è‰é¦™å‘³ï¼›ä¸‰ç¨®ä¸»è¦æˆä»½å«é‡ç‚ºï¼š

**èŸ²è‰èŒçµ²é«” 2000mg/6 é¡†ï¼ŒçŸ³æ¦´èƒå–ç‰© 170mg/6 é¡†ï¼Œäººåƒèƒå–ç‰© 100mg/6 é¡†ï¼Œå…± 2270mgã€‚**

âš ï¸âš ï¸âš ï¸ï¼ˆæ¯å€‹åœ‹å®¶è£¡çš„é…æ–¹å¤šå°‘æœƒæœ‰èª¿æ•´ï¼Œä¾ç…§ç•¶åœ°å¸‚å ´ç‚ºä¸»ã€‚ï¼‰

å› ç‚ºæ¯ä¸€å€‹æˆåˆ†å–®ç¨æ‹†å‡ºå°±å¯ä»¥é–‹ä¸€ç¯‡ä¾†è¬›ï¼Œå…ˆçœ‹ã€Šæ—¥éŒ ã€‹æˆåˆ†ç¸±åˆåŠŸæ•ˆï¼š

  * èŸ²è‰èŒçµ²é«”å…·æœ‰å¼·æŠ—æ°§åŒ–åŠ›ï¼Œæœ‰æ•ˆæ¸›å°‘è‡ªç”±åŸºç”¢ç”Ÿã€æŠ—è…«ç˜¤ã€èª¿ç¯€å…ç–«åŠ›å’Œæ”¹å–„ç–²å‹æ•ˆæœï¼Œè€Œå…¶ä¸­çš„**èŸ²è‰é…¸** ï¼ˆD-Mannitolï¼‰äº¦èƒ½èª¿ç¯€å¹³è¡¡ï¼Œæœ‰åŠ©æ–¼ğŸ‘‰**ä¿ƒé€²ç”·æ€§åŠŸèƒ½ä¿é¤Š** ã€ğŸ‘‰å¢**åŠ ç”·æ€§é­…åŠ›** ã€ğŸ‘‰**å¢å¼·é«”åŠ›åŠå…ƒæ°£** ã€‚
  * äºæ´²äººè”˜æ˜¯äºæ´²å¸¸è¦‹è—¥æï¼ŒåŒæ™‚ä¹Ÿèƒ½å¢åŠ è¶…æ°§åŒ–ç‰©æ­§åŒ–é…¶å’Œéæ°§åŒ–æ°«é…¶åœ¨è¡€æ¶²ä¸­çš„å«é‡ï¼Œå…·æœ‰æŠ—æ°§åŒ–ä½œç”¨ã€‚è€Œäººè”˜ä¸­å¯Œå«**äººè”˜çš‚è‹·** ï¼ˆGinsenosideï¼‰ç”¨æ–¼ğŸ‘‰**ç—…å¾Œæ¢å¾©** ã€ğŸ‘‰**å¢å¼·é«”åŠ›** ã€ğŸ‘‰**èª¿ç¯€è·çˆ¾è’™** ã€ğŸ‘‰**æŠ—è¡°è€** ã€ğŸ‘‰**å¢å¼·æ€§æ©Ÿèƒ½** ã€ğŸ‘‰**æ§åˆ¶è¡€ç³–è¡€å£“å’Œè‚åŠŸèƒ½ä¿å¥** ã€ğŸ‘‰**æé«˜è€å¹´äººè¨˜æ†¶åŠ›èƒ½åŠ›** ã€‚
  * çŸ³æ¦´æå–ç‰©å‰‡å«æœ‰æœ€è¿‘ç•¶ç´…çš„æŠ—è¡°è€ç‰©**å°¿çŸ³ç´ ** ï¼ˆUrolithinï¼‰ï¼Œå¯ä»¥ğŸ‘‰**é™è¡€å£“** ã€ğŸ‘‰**æ”¹å–„è¨˜æ†¶åŠ›** ã€ğŸ‘‰**æ¸›è¼•ç‚ç—‡** ã€ğŸ‘‰**ä¿è­·è¡€ç®¡å½ˆæ€§** ã€ğŸ‘‰**é™è¡€ç³–** ã€ğŸ‘‰**ä¿è­·è‚è‡Ÿ** ã€‚

## **ä½¿ç”¨ ageLOC R2ã€Šæ—¥éŒ ã€‹æ„Ÿå—ï¼š**

å¥—ç”¨ä¿åŠ›é” B çš„å»£å‘Šè©ï¼šã€Œæ˜å¤©çš„æ°£åŠ›ï¼Œä»Šå¤©å°±çµ¦ä½ å‚³ä¾¿ä¾¿ï¼ã€ï¼›

é‚£ä½¿ç”¨ ageLOC R2 ã€Šæ—¥éŒ ã€‹æ„Ÿå—å°±æ˜¯

**ä»Šæ™šçš„æ°£åŠ›ï¼Œé€æ—©å°±çµ¦ä½ å‚³ä¾¿ä¾¿ï¼**

**ä»Šæ™šçš„è¡¨ç¾ï¼Œå°±æ˜¯æ˜å¤©çš„æœ€ä½æ¨™ï¼**

## **ã€Šå¤œéŒ ã€‹ï¼šå¤œå¤œæ¸…æ·¨**

è£¡é¢ 30 æ—¥ä»½ï¼Œä¸€æ¬¡ 2 é¡†ï¼Œå…± 60 é¡†ã€‚

è·Ÿç™½å¤©çš„è† å›Šé¡è‰²ä¸åŒï¼Œæ˜¯ç£šç´…è‰²ï¼Œçœ‹å¾—å‡ºä¾†è£¡é¢æœ‰è±å¯Œçš„æ¤ç‰©èƒå–ç‰©ã€‚

ä¸‰ç¨®ä¸»è¦æˆä»½å«é‡ç‚ºï¼š

**è‘¡è„ç±½èƒå–ç‰© 210mg/2 é¡†ã€è¡€æ©™èƒå–ç‰© 125mg/2 é¡†åŠé’èŠ±æ¤°èœç±½èƒå–ç‰© 115mg/2 é¡†ï¼Œå…± 450mg** ã€‚

**ï¼ˆå°ç£é…æ–¹ç‚ºï¼šè‘¡è„ç±½èƒå–ç‰© 210mg/2 é¡†ã€è¡€æ©™èƒå–ç‰© 125mg/2 é¡†ã€æ©„æ¬–è‘‰æå–ç‰© 200mg/2 é¡†ã€æ©„æ¬–æœæå–ç‰© 67mg/2 é¡†ã€è¼”é…¶Q 10 75mg/2 é¡†ã€‚ï¼‰**

âš ï¸âš ï¸âš ï¸ï¼ˆæ¯å€‹åœ‹å®¶è£¡çš„é…æ–¹å¤šå°‘æœƒæœ‰èª¿æ•´ï¼Œä¾ç…§ç•¶åœ°å¸‚å ´ç‚ºä¸»ã€‚ï¼‰

å› ç‚ºæ¯ä¸€å€‹æˆåˆ†å–®ç¨æ‹†å‡ºå°±å¯ä»¥é–‹ä¸€ç¯‡ä¾†è¬›ï¼Œä¾†çœ‹ã€Šå¤œéŒ ã€‹æˆåˆ†ç¸±åˆåŠŸæ•ˆï¼š

  * è‘¡è„ç±½èƒå–ç‰©å«æœ‰**ä½èšåŸèŠ±é’ç´ ** ï¼ˆOligomeric Proanthocyanidinsï¼ŒOPCï¼‰èˆ‡æœ‰å¤§é‡çš„é¡é»ƒé…®ä»¥åŠå¤šé…šé¡æŠ—æ°§åŒ–åŠ‘ï¼Œå¯ä»¥ğŸ‘‰**ä¿è­·å¿ƒè‡Ÿ** ã€ğŸ‘‰**é™ä½è†½å›ºé†‡** ã€ğŸ‘‰**ä¿è­·è¡€ç®¡ã€‚**
  * è¡€æ©™èƒå–ç‰©å«æœ‰ç¶­ä»–å‘½ Cã€ç¶­ä»–å‘½ E å’Œ Î²-èƒ¡è˜¿è””ç´ ï¼ŒåŠ ä¸Š**èŠ±é’ç´ ** ï¼ˆAnthocyaninï¼‰å…·æœ‰**æŠ—æ°§åŒ–ï¼Œé é˜²å¿ƒè¡€ç®¡ç–¾ç—…åŒæŠ‘åˆ¶ç™Œç—‡ç­‰ä½œç”¨** ã€‚ èŠ±é’ç´ è‹·å’Œé¡é»ƒé…®ç­‰å¤šé…šåŒ–åˆç‰©ï¼Œå‰‡å…·æœ‰ğŸ‘‰**æ¶ˆè„‚** ã€ğŸ‘‰**æŠ—å‡è¡€** ã€ğŸ‘‰**æŠ—æ°§åŒ–** ã€ğŸ‘‰**ä¿é¤Šè¡€ç®¡** å’ŒğŸ‘‰**é¤Šé¡ç¾å®¹** çš„ä½œç”¨ã€‚
  * ç¶ èŠ±æ¤°èœç±½èƒå–ç‰©å«æœ‰å¤§é‡**ç¡«ä»£è‘¡è„ç³–è‹·** ï¼ˆGlucosinolateï¼‰ï¼Œæ°´è§£ç”¢ç”Ÿçš„**ç•°ç¡«æ°°é…¸é…¯** ï¼ˆIsothiocyanatesï¼‰ï¼Œèƒ½èª˜å°è‚è‡Ÿç¬¬äºŒéšæ®µï¼ˆPhase â…¡ Enzymeï¼‰çš„æ’æ¯’ä½œç”¨ï¼Œè¨±å¤šç¶²è·¯è³‡æ–™å¸¸æåˆ°èŠ±æ¤°èœå…·æœ‰è§£æ¯’æŠ—ç™Œçš„åŠŸæ•ˆï¼Œä¸»è¦æ˜¯å› ç‚ºç¶ èŠ±æ¤°èœä»¥å«è±å¯Œçš„å‰é©…ç‰©è³ª**è˜¿è””ç¡«è‹·** ï¼ˆGlucoraphaninï¼‰å­˜åœ¨ï¼Œç•¶æ¤ç‰©å—åˆ°ç ´å£ï¼ˆåˆ‡ç¢ã€å’€åš¼ï¼‰æ™‚æœƒåˆ†æ³Œ**èŠ¥å­é…¶** ï¼ˆMyrosinaseï¼‰ï¼Œå°‡è˜¿è””ç¡«è‹·è½‰æ›æˆå…·æ´»æ€§çš„**è˜¿è””ç¡«ç´ ** ï¼ˆSulforaphaneï¼‰ï¼Œåœ¨ç´°èƒä¸­çš„ Nrf2 ä¿¡è™Ÿé€šé“è¢«æ¿€æ´»ï¼Œç™¼æ®ğŸ‘‰**æŠ—æ°§åŒ–** ã€ğŸ‘‰**æŠ—ç™¼ç‚** ã€ğŸ‘‰**ç¥ç¶“ä¿è­·** èˆ‡ğŸ‘‰**æŠ—ç™Œ** çš„æ•ˆæœã€‚

## **ä½¿ç”¨ ageLOC R2ã€Šå¤œéŒ ã€‹æ„Ÿå—ï¼š**

ä½ æ˜¯å¦ä¹Ÿæ›¾åœ¨äº”æ˜Ÿç´šé£¯åº—ä¸€å¤œå¥½çœ å¾Œï¼Œç”¢ç”Ÿå¥½å¥‡æƒ³çŸ¥é“é«˜æª”é£¯åº—ç©¶ç«Ÿæ˜¯ä½¿ç”¨å“ªä¸€å“ç‰ŒåºŠå¢Šï¼Ÿ

æ€éº¼é‚£éº¼èˆ’æœã€é‚£éº¼æ”¾é¬†ï¼Ÿ

**å°±åƒåœ¨äº”æ˜Ÿç´šé£¯åº—ä¸€å¤œå¥½çœ ï¼èº«é«”é‚£éº¼è¼•é¬†ï¼**

**å…¨èº«å¥½åƒåšéæŒ‰æ‘© SPA èˆ’æœï¼**

## **é‚£éº¼å²å®³çš„ ageLOC R2 è£¡é¢å«ä»€éº¼æŠ€è¡“**

**ç†å¯Ÿï¼é­å¾·é­¯** ï¼ˆRichard Weindruchï¼‰èˆ‡**æ¹¯é¦¬å£«ï¼ä¿ç¾…æ‹‰** ï¼ˆTomas A. Prollaï¼‰åœ˜éšŠåœ¨è¥¿å…ƒ 1999 å¹´ç™¼è¡¨åœ¨ç†±é‡é™åˆ¶æ–¹å¼ä¸‹æœ‰å“ªäº›**åŸºå› ** ï¼ˆGeneï¼‰ä¹Ÿå—åˆ°äº†èª¿æ§å¾Œï¼Œé€éåŸºå› æ™¶ç‰‡é–‹å§‹å¤§é‡çš„æƒæç›¸é—œçš„åŸºå› ã€‚

ç™¼ç¾**ç›¸åŒçš„åŸºå› åœ¨ä¸åŒçš„çµ„ç¹”è£¡è¡¨ç¾ä¹Ÿä¸è¦‹å¾—ç›¸åŒï¼Œå¦å¤–å–®ä¸€æœ‰æ•ˆæˆä»½ç›¸ç–ŠåŠ å¾Œå½±éŸ¿åŸºå› çš„æ•ˆæœä¹Ÿæœƒæœ‰å¾ˆå¤§çš„å·®ç•°** ã€‚

Affymetrix Biochip

ageLOC æ¼”é€²æ­·å²è«‹çœ‹é€™ç¯‡ï¼šğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡

> [é›†æŠ—è¡°è€è¿‘ç™¾å¹´ç ”ç©¶å¤§æˆâ€”å‚³æ‰¿è‡ªç†±é‡é™åˆ¶æ³•ä¹‹ageLOCæŠ€è¡“çš„èª•ç”Ÿ](https://agelocked.com/%e9%9b%86%e6%8a%97%e8%a1%b0%e8%80%81%e8%bf%91%e7%99%be%e5%b9%b4%e7%a0%94%e7%a9%b6%e5%a4%a7%e6%88%90-%e5%82%b3%e6%89%bf%e8%87%aa%e7%86%b1%e9%87%8f%e9%99%90%e5%88%b6%e6%b3%95%e4%b9%8bageloc/)

## **ageLOC R2 ç§‘å­¸å¯¦è­‰**

## **å‹•ç‰©å¯¦é©—éƒ¨åˆ†ï¼š**

### **ä¸€ã€ageLOC R2ã€Šæ—¥éŒ ã€‹æ”¹å–„åœ¨è¡°è€æ¨¡å‹ä¸­ï¼Œé‹å‹•æ™‚çš„è‘¡è„ç³–ä»£è¬ã€é‹å‹•è€åŠ›å’ŒæŠ—æ°§åŒ–èƒ½åŠ›**

åœ¨é€™é …ç ”ç©¶ä¸­ï¼Œå°‡ã€Šæ—¥éŒ ã€‹ï¼ˆ0.4 æˆ– 0.8 g/kgï¼‰é¤µé£Ÿ 10 å€‹æœˆé½¡çš„ ICR å°é¼  47 å¤©çš„æ•ˆæœã€‚

è² é‡æ¸¸æ³³å¯¦é©—ä½œç‚ºè€åŠ›çš„æ¸¬é‡æŒ‡æ¨™ï¼Œèˆ‡é‹å‹•å°ç…§çµ„ç›¸æ¯”ï¼Œé¤µé£Ÿ 0.8 g/kg ã€Šæ—¥éŒ ã€‹çš„å°é¼ è² é‡æ¸¸æ³³è‡³ç–²å‹çš„æ™‚é–“å¢åŠ äº† 22%ã€‚

ã€Šæ—¥éŒ ã€‹çš„é¤µé£Ÿæ¸›è¼•äº†å› é‹å‹•å¼•èµ·çš„**è…“è…¸è‚Œ** ï¼ˆGastrocnemiusï¼‰å’Œè‚ç³–æ¶ˆè€—ï¼Œä¸¦ä¸”æ¸›å¼±äº†å› é‹å‹•å¼•èµ·çš„è‚Œè‚‰ä¸­çš„è‡ªç”±åŸºï¼ˆROSï¼‰å‡é«˜ã€‚

**çµè«–** ï¼š**ageLOC R2ã€Šæ—¥éŒ ã€‹å»¶é•·äº†è€å¹´å°é¼ è² é‡æ¸¸æ³³çš„æ™‚é–“ï¼Œé€šéæ”¹å–„ç´°èƒè‚é†£ä¿å­˜å’ŒæŠ—æ°§åŒ–èƒ½åŠ›ï¼Œè¡¨æ˜ ageLOC ã€Šæ—¥éŒ ã€‹åœ¨å¢å¼·è€å¹´äººçš„è€åŠ›é‹å‹•èƒ½åŠ›å’Œé é˜²è‚Œè‚‰è€åŒ–æ–¹é¢å…·æœ‰æ½›åœ¨ç›Šè™•ã€‚**

### **äºŒã€ageLOC R2 ã€Šæ—¥éŒ ã€‹å¢å¼·æ­£å¸¸å’Œé™½ç—¿æ¨¡å‹çš„æ€§åŠŸèƒ½**

1.å¤§é¼ å¯¦é©—ï¼š3 å€‹æœˆé½¡çš„å¤§é¼ æ¥å—äº†**é›™é‚Šå»å‹¢æ‰‹è¡“** ï¼ˆBilateral Orchiectomyï¼‰ï¼Œå°è‡´**å‹ƒèµ·å»¶é²** ï¼ˆErection Latencyï¼ŒELï¼‰ã€‚

åœ¨è¶…é 5 å‘¨çš„ä¼‘æ¯å¾Œï¼Œå»å‹¢å¤§é¼ è¢«çµ¦äºˆ 3 å¤©çš„åŸºç¤è™•ç†æˆ– 0.2 æˆ– 0.8 g/kg åŠ‘é‡çš„ã€Šæ—¥éŒ ã€‹çŒé£Ÿã€‚

èˆ‡å»å‹¢å°ç…§çµ„ç›¸æ¯”ï¼Œå–®æ¬¡åŠ‘é‡çš„ã€Šæ—¥éŒ ã€‹ä»¥åŠç‚ºæœŸ 3 å¤©çš„0.8 g/kg åŠ‘é‡çš„è™•ç†å‡ç¸®çŸ­äº†å»å‹¢æ‰‹è¡“å¤§é¼ çš„å‹ƒèµ·å»¶é²ã€‚

2\. å°é¼ å¯¦é©—ï¼š8 å€‹æœˆé½¡çš„ ICR å°é¼ æ¥å—äº† 0.4 æˆ– 0.8 g/kg çš„ã€Šæ—¥éŒ ã€‹è™•ç† 20 å¤©ï¼Œéš¨å¾Œæª¢æ¸¬**æ•ç²å»¶é²** ï¼ˆCapture Latencyï¼ŒCLï¼‰å’Œ **20 åˆ†é˜å…§çš„æ•ç²æ¬¡æ•¸** ï¼ˆCapture Times within 20 minï¼ŒCT20ï¼‰ã€‚

ä½¿ç”¨ 0.4 g/kg åŠ‘é‡çš„ã€Šæ—¥éŒ ã€‹å¾Œï¼ŒCL ç¸®çŸ­ã€‚åœ¨ç¬¬ 3 å¤©ä½¿ç”¨ 0.4 g/kg åŠ‘é‡å¾Œï¼ŒCT20 å¢åŠ äº† 78%ï¼Œåœ¨ç¬¬ 20 å¤©ä½¿ç”¨ 0.8 g/kg åŠ‘é‡å¾Œï¼ŒCT20 å¢åŠ äº† 109% ã€‚

Screenshot

**çµè«–ï¼šageLOC R2ã€Šæ—¥éŒ ã€‹é€šéç¸®çŸ­å»å‹¢å¤§é¼ çš„å‹ƒèµ·å»¶é²ï¼ˆELï¼‰ï¼Œä»¥åŠç¸®çŸ­å°é¼ çš„æ•ç²æ½›ä¼æœŸï¼ˆCLï¼‰å’Œå¢åŠ  20 åˆ†é˜å…§çš„æ•ç²æ¬¡æ•¸ï¼ˆCT20ï¼‰ä¾†å¢å¼·æ€§è¡Œç‚ºã€‚**

### **ä¸‰ã€ageLOC R2ã€Šæ—¥éŒ ã€‹æ”¹å–„è¨˜æ†¶éšœç¤™æ¨¡å‹çš„è¨˜æ†¶èˆ‡å­¸ç¿’èƒ½åŠ›**

æ­¤ç¯‡ç ”ç©¶ä½¿ç”¨**ç©¿æ¢­ç®±** è©¦é©—ä¸¦é¤µé£Ÿ 0.2ã€0.4 æˆ– 0.8g/kg åŠ‘é‡çš„ã€Šæ—¥éŒ ã€‹æ¢è¨å°å°é¼ è¨˜æ†¶åŠŸèƒ½çš„å½±éŸ¿ã€‚

ï¼ˆè¨»ï¼š**ç©¿æ¢­ç®±è©¦é©—** ï¼ˆshuttle-box testï¼‰ä¹Ÿç¨±ç‚ºä¸»å‹•å›é¿å¯¦é©—ï¼Œå®ƒæ˜¯ä»¥å…‰å’Œ/æˆ–è²éŸ³ã€é›»æ“Šç‚ºè¯åˆåˆºæ¿€ï¼Œä½¿å¯¦é©—å‹•ç‰©ç”±è¢«å‹•å›é¿å»ºç«‹ä¸»å‹•çš„æ¢ä»¶åå°„ï¼Œä¾†è¨˜éŒ„æ­¤æ¢ä»¶åå°„å»ºç«‹éç¨‹ä¸­çš„ä¸»å‹•å›é¿åæ‡‰æŒ‡æ¨™ï¼Œå¯åæ‡‰å¯¦é©—å‹•ç‰©çš„å­¸ç¿’ã€è¨˜æ†¶èƒ½åŠ›çš„è®ŠåŒ–ã€‚ï¼‰

ä½¿ç”¨äº†**è¨˜æ†¶ç²å–çš„æå‚·** ï¼ˆ Memory Acquisition Impairmentï¼ŒMAIï¼‰ã€**è¨˜æ†¶éå›ºçš„æå‚·** ï¼ˆMemory Aonsolidation Impairmentï¼ŒMCIï¼‰å’Œ**è¨˜æ†¶å†ç¾çš„æå‚·** ï¼ˆMemory Reproduction Impairmentï¼ŒMRIï¼‰ä¸‰ç¨®æ¨¡å‹ã€‚

åœ¨ç©¿æ¢­ç®±è¿´é¿æ¸¬è©¦ä¸­ï¼Œã€Šæ—¥éŒ ã€‹ç¸®çŸ­äº†ï¼š

(1) åœ¨ MAI æ¨¡å‹ä¸­çš„**ä¸»å‹•è¿´é¿å»¶é²** ï¼ˆActive Avoidance Latencyï¼ŒAALï¼‰ä¸¦æé«˜äº†**ä¸»å‹•è¿´é¿åæ‡‰é€Ÿç‡** ï¼ˆActive Avoidance Response Rateï¼ŒAARRï¼‰ï¼šAAL -47 ~ -70% å’Œ AARR +109 ~ +209% ï¼› 

(2) åœ¨ MCI æ¨¡å‹ä¸­ï¼šAAL +9.5 ~ -44% åŠ AARR +59 ~ +149% ï¼› 

(3) åœ¨ MRI æ¨¡å‹ä¸­ ï¼šAAL +10 ~ -52% å’Œ AARR +17 ~ +203% ã€‚

**çµè«–ï¼šageLOC R2ã€Šæ—¥éŒ ã€‹å¯æœ‰æ•ˆæ”¹å–„è¨˜æ†¶éšœç¤™å°é¼ çš„è¨˜æ†¶å’Œå­¸ç¿’èƒ½åŠ›ã€‚**

### **å››ã€ageLOC R2 ã€Šå¤œéŒ ã€‹å¢å¼·ç²’ç·šé«”è§£æ¯’åŠŸèƒ½**

åˆ†æˆä¸‰çµ„ CBA/J å°é¼ ï¼› æ¯çµ„ï¼ˆn = 8ï¼‰ï¼Œé¤µé£Ÿ 3 å€‹æœˆã€‚

1\. å¹´è¼•å°ç…§çµ„ï¼ˆYoung Controlï¼ŒYCï¼‰ï¼› 2 å€‹æœˆé½¡çš„ CBA/J å°é¼ ï¼› ä½¿ç”¨ AIN 93M é£²é£Ÿï¼Œæ­¤é£²é£Ÿå°ˆç‚º**æˆå¹´å›“é½’å‹•ç‰©** ï¼ˆadult rodentsï¼‰è¨­è¨ˆã€‚  
2.ä¸­å¹´æ§åˆ¶çµ„ï¼ˆMiddle-Age Controlï¼ŒMACï¼‰ï¼› 16 å€‹æœˆé½¡çš„ CBA/J å°é¼ ï¼› ä½¿ç”¨ AIN 93M é£²é£Ÿã€‚  
3.ä¸­å¹´è£œå……åŠ‘çµ„ï¼ˆMiddle-Age Supplementedï¼ŒMASï¼‰ï¼› 16 å€‹æœˆé½¡çš„ CBA/J å°é¼ ï¼› ä½¿ç”¨ AIN 93M é£²é£Ÿæ­é… ageLOC R2 é…æ–¹ã€‚

3 å€‹æœˆå¾Œå–**è‚è‡Ÿ** ï¼ˆLiverï¼‰èˆ‡**è…“è…¸è‚Œ** ï¼ˆGastrocnemiusï¼‰çš„çµ„ç¹”ï¼Œä¾†çœ‹åŸºå› è¡¨ç¾åœ–è­œé€²è¡Œæ¯”è¼ƒï¼Œä»¥ç¢ºå®šåŸºå› è¡¨ç¾çš„è®ŠåŒ–å¹´é½¡ï¼ˆMAC èˆ‡ YCï¼‰ä»¥åŠå° ageLOC R2 é…æ–¹çš„åæ‡‰ï¼ˆMAS èˆ‡ MACï¼‰ã€‚

  *   *   * Screenshot

å¯ä»¥çœ‹å‡ºæ­¤åŸºå› åœ–è­œèˆ‡ Nrf2 pathway è·¯å¾‘ç›¸é—œï¼ŒNrf2 å­˜åœ¨æ–¼ç´°èƒè³ªä¸­ã€‚

**æ˜¯é–‹å•Ÿå°ç²’ç·šé«”åŠŸèƒ½å¾ˆé‡è¦çš„åŸºå› ï¼Œèª¿æ§äººé«”æœ€å¼·å¤§çš„æŠ—æ°§åŒ–è·¯å¾‘ä¹‹ä¸€ã€‚**

ç•¶ç´°èƒé­å—åˆ°æ°§åŒ–å£“åŠ›æ™‚ï¼ŒKeap1 è›‹ç™½æœƒèˆ‡ Nrf2 åˆ†é›¢ï¼Œä½¿ Nrf2 å¾—ä»¥é€²å…¥ç´°èƒæ ¸ã€‚

é€²å…¥ç´°èƒæ ¸å¾Œï¼ŒNrf2 æœƒèˆ‡**æŠ—æ°§åŒ–åæ‡‰å…ƒä»¶** ï¼ˆAntioxidant Response Elementsï¼ŒAREï¼‰çµåˆï¼Œå•Ÿå‹•ç›¸é—œåŸºå› çš„è¡¨é”ï¼Œè½‰éŒ„å‡ºè¨±å¤šæŠ—æ°§åŒ–å’Œæ’æ¯’çš„ RNA ç‰‡æ®µï¼Œé€™äº›ç‰‡æ®µé€²ä¸€æ­¥æŒ‡å°ç´°èƒåˆæˆæŠ—æ°§åŒ–é…¶å’Œè§£æ¯’é…¶ã€‚

### **è‚è‡Ÿå…§çš„æŠ—æ°§åŒ–é…¶å’Œè§£æ¯’é…¶**

è‚è‡Ÿè§£æ¯’åˆ†æˆå…©å€‹éšæ®µï¼›

**è‚è‡Ÿè§£æ¯’ç¬¬ä¸€éšæ®µï¼ˆPhase I Detoxificationï¼‰**

  * é€™å€‹éšæ®µæ˜¯è¦æŠŠè„‚æº¶æ€§æ¯’ç´ ï¼Œç¶“ç”±ç‰¹æ®Šçš„é…µç´ ï¼Œè½‰è®Šæˆã€Œæ°´æº¶æ€§ä¸­é–“ç”¢ç‰©ã€ï¼Œé€™ç¨®ä¸­é–“ç”¢ç‰©çš„æ¯’æ€§æ¯”åŸä¾†çš„è„‚æº¶æ€§æ¯’ç´ å¼·å¾ˆå¤šï¼Œæ‰€ä»¥å¿…é ˆè¶•å¿«é€²å…¥ä¸‹ä¸€éšæ®µï¼Œä»¥å…å‚·åˆ°è‡ªå·±çš„ç´°èƒè†œå’Œ DNAã€‚
  * æŠŠè„‚æº¶æ€§æ¯’ç´ è½‰åŒ–æˆã€Œç‡™æ‰‹å±±èŠ‹ã€çš„é€™ä¸€ç¾¤ç‰¹æ®Šé…µç´ ï¼Œç¨±ç‚ºã€Œ**ç´°èƒè‰²ç´ P-450** ï¼ˆCytochrome P-450ï¼‰é…µç´ ç³»çµ±ã€ï¼Œç°¡ç¨±ã€ŒP450sã€ã€‚
  * å¦å¤– **NAD(P)H å°è‹¯äºŒé…®è„«æ°«é…¶** ï¼ˆNAD(P)H-Quinone Oxidoreductase 1 ï¼ŒNQO1ï¼‰ä¸»è¦åˆ†å¸ƒæ–¼ç´°èƒçš„ç²’ç·šé«”ã€å¾®ç²’é«”ã€ç´°èƒè†œã€èˆ‡ç´°èƒè³ªä¸­ï¼Œå°‘æ•¸åˆ†å¸ƒæ–¼ç´°èƒæ ¸ä¸­ã€‚
  * NQO1 å‚¬åŒ–é†ŒåŒé›»å­é‚„åŸåæ‡‰ï¼Œå¯è§£**è‹¯é¡** ï¼ˆBenzeneï¼‰èˆ‡**é†Œé¡** ï¼ˆQuinineï¼‰è¡ç”Ÿç‰©ã€‚

**è‚è‡Ÿè§£æ¯’ç¬¬äºŒéšæ®µï¼ˆPhase II Detoxificationï¼‰**

  * ç¬¬äºŒéšæ®µå°±æ˜¯è¦æŠŠæ¯’æ€§è¶…å¼·çš„ã€Œæ°´æº¶æ€§ä¸­é–“ç”¢ç‰©ã€ï¼Œè½‰è®Šæˆç„¡æ¯’çš„ã€Œæ°´æº¶æ€§çµ‚ç«¯ç”¢ç‰©ã€ï¼Œå¾è†½æ±ä¸­æ’å‡ºï¼Œé€²å…¥è…¸é“ï¼Œè¢«é£Ÿç‰©ä¸­çš„çº–ç¶­è³ªå¸é™„ï¼Œè®Šæˆç³ä¾¿æ’å‡ºã€‚ä¹Ÿå¯é€²å…¥è¡€æ¶²ï¼Œå¾ªç’°åˆ°è…è‡Ÿï¼Œå¾å°¿æ¶²ä¸­æ’å‡ºã€‚
  * **æ¦–èƒ±ç”˜è‚½è½‰ç¡«é…¶** ï¼ˆGlutathione S-transferasesï¼ŒGSTsï¼‰çš„ä½œç”¨åœ¨ä¿è­·èº«é«”å°æŠ—æ°§åŒ–å£“åŠ›ï¼Œé™ä½é«”å…§çš„**éæ°§åŒ–æ°«** ï¼ˆHydrogen Peroxideï¼‰èˆ‡å¢åŠ ç¶­ç”Ÿç´  C èˆ‡ E çš„æŠ—æ°§åŒ–èƒ½åŠ›ã€‚åœ¨é«”å…§ GSTs æ˜¯è‚è‡Ÿç¬¬äºŒéšæ®µè§£æ¯’éç¨‹ä¸­çš„é‡è¦é…µç´ ã€‚
  * GSTs å«å¤šç¨®é¡å‹ï¼Œ**æ¦–èƒ±ç”˜è‚½è½‰ç¡«é…¶ M1** ï¼ˆGlutathione S-transferase M1ï¼ŒGSTM1ï¼‰æ˜¯å…¶ä¸­ä¹‹ä¸€ï¼Œå»£æ³›å­˜åœ¨æ–¼è‚è‡Ÿä¸­ï¼Œå¦å¤–**æ¦–èƒ±ç”˜è‚½è½‰ç¡«é…¶ T1** ï¼ˆlutathione S-transferase T1ï¼ŒGSTT1ï¼‰ä¹Ÿæ˜¯é‡è¦çš„é…µç´ ä¹‹ä¸€ã€‚

**çµè«–ï¼šageLOC R2 é…æ–¹èƒ½åˆºæ¿€æŠ—æ°§åŒ–é…¶å’Œè§£æ¯’é…¶çš„åŸºå› è¡¨ç¾ï¼Œå¢åŠ è›‹ç™½é…¶çš„åˆæˆã€‚**

## **äººé«”å¯¦é©—éƒ¨åˆ†ï¼š**

### **ä¸€ã€**[**å—è©¦è€…ä½¿ç”¨ã€Šæ—¥éŒ ã€‹å°æ–¼èº«é«”ã€å¿ƒéˆã€æ€§æ…¾èˆ‡æŠ—æ°§åŒ–æ´»æ€§çš„å½±éŸ¿**](https://china.nuskin.com/content/dam/ns-zh/pdf/learning/33.%20Effects%20of%20A%20Novel%20Dietary%20Supplement%20on%20Physical%20and%20Mental%20Function%20in%20Middle-Aged%20Adults%20A%20Double-Blind,%20Randomized,%20Placebo-Controlled%20Trial.pdf)

æ‹›å‹Ÿäº† 116 åå—è©¦è€…ï¼ˆ55 åç”·æ€§ï¼Œ56 åå¥³æ€§ï¼‰åƒèˆ‡é€™é …é›™ç›²ã€éš¨æ©Ÿç ”ç©¶ï¼Œå¹´é½¡ç¯„åœç‚º 40 ~ 70 æ­²ã€‚

å—è©¦è€…è¢«éš¨æ©Ÿåˆ†ç‚ºå…©å€‹æ¸¬è©¦çµ„ï¼šæŒçºŒäº†å…«é€±è£œå……ã€Šæ—¥éŒ ã€‹ç¨±ç‚ºå¯¦é©—çµ„ï¼ˆn=60ï¼‰å’Œä½¿ç”¨å®‰æ…°åŠ‘çš„å°ç…§çµ„ï¼ˆn=56ï¼‰ã€‚

**æ•´é«”ç”Ÿç†åŠŸèƒ½å•å·** ï¼ˆPhysical Component Scaleï¼ŒPCSï¼‰ï¼ˆèº«é«”æ´»å‹•åŠŸèƒ½ã€èº«é«”è§’è‰²ã€èº«é«”ç–¼ç—›åŠä¸€èˆ¬å¥åº·ç‹€æ³ï¼‰ï¼›**æ•´é«”å¿ƒç†åŠŸèƒ½å•å·** (Mental Component Scaleï¼ŒMCS)ï¼ˆæ´»åŠ›ç‹€æ³ã€ç¤¾äº¤åŠŸèƒ½ã€å¿ƒç†å¥åº·ç‹€æ³èˆ‡æƒ…ç·’ç‹€æ³ï¼‰èˆ‡**æ€§éœ€æ±‚æŒ‡æ•¸** ï¼ˆSexual Desire Scoreï¼‰é€éç¶“éé©—è­‰çš„å•å·é€²è¡Œæ¸¬é‡ï¼›

ä½¿ç”¨ PharmanexÂ® ç”Ÿç‰©å…‰å­æƒæå™¨æ¸¬é‡æ¯å€‹å—è©¦è€…çš„çš®è†šé¡èƒ¡è˜¿è””ç´ æ¿ƒåº¦ï¼Œä»¥äº†è§£å°æŠ—æ°§åŒ–æ´»æ€§çš„å½±éŸ¿ã€‚

ä½¿ç”¨ã€Šæ—¥éŒ ã€‹é–‹å§‹å‰ï¼ˆç¬¬ 0 å¤©ï¼‰é€²è¡Œç¬¬ä¸€æ¬¡çš„æ¸¬é‡ï¼Œéš¨å¾Œåœ¨ 8 å‘¨ï¼ˆç¬¬ 56 å¤©ï¼‰å¾Œæ¸¬é‡ã€‚ ç„¶å¾Œå°å„çµ„é€²è¡Œäº†ç¸½çµå’Œæ¯”è¼ƒå¾—åˆ†ã€‚

**çµè«–ï¼šageLOC R2 ã€Šæ—¥éŒ ã€‹å¯æœ‰æ•ˆå¢åŠ æŠ—æ°§åŒ–èƒ½åŠ›**

### **äºŒã€ageLOC R2ã€Šæ—¥éŒ ã€‹æ”¹å–„é‹å‹•æ™‚çš„è‘¡è„ç³–ä»£è¬å’Œå¢åŠ èªçŸ¥èƒ½åŠ›**

ã€Šæ—¥éŒ ã€‹çš„é¤µé£Ÿæ¸›è¼•äº†å› é‹å‹•å¼•èµ·çš„**è…“è…¸è‚Œ** ï¼ˆGastrocnemiusï¼‰å…§çš„è‚ç³–æ¶ˆè€—ï¼Œéš¨è‘—åŠ‘é‡å¢åŠ è€Œæ¶ˆè€—æ¸›å°‘ã€‚

ç¶œåˆèªçŸ¥æŒ‡æ•¸ä¹Ÿéš¨è‘—ä½¿ç”¨ 12 é€±å¾Œå¢åŠ  20%ã€‚

ï¼ˆè¨»ï¼šç¶œåˆèªçŸ¥æŒ‡æ•¸ï¼ˆComposite Cognition Indexï¼ŒCCIï¼‰ï¼šåæ‡‰æ™‚é–“ã€çŸ­æœŸè¨˜æ†¶ã€åŸ·è¡ŒåŠŸèƒ½ã€è¨Šæ¯è™•ç†ã€æ¨¡å¼è¾¨è­˜èˆ‡å·¥ä½œ  
è¨˜æ†¶åŠ ç¸½çš„å…­é …å¹³å‡åˆ†æ•¸ï¼‰

age-related vitality

**çµè«–ï¼šageLOC R2 ã€Šæ—¥éŒ ã€‹å¯æœ‰æ•ˆå¢åŠ ç¶œåˆèªçŸ¥èƒ½åŠ›**

å°ç£ç‰ˆçš„é…æ–¹æœ‰èª¿æ•´éï¼Œå°¤å…¶æ˜¯ã€Šæ—¥éŒ ã€‹è£¡é‚„æ·»åŠ äº†**å·¦æ—‹ç²¾æ°¨é…¸** ï¼ˆL-Arginineï¼‰ï¼ï¼

å®ƒè¢«è½‰åŒ–ç‚º**ä¸€æ°§åŒ–æ°®** ï¼ˆNOï¼‰ï¼Œä¸€æ°§åŒ–æ°®èƒ½ä½¿è¡€ç®¡å¹³æ»‘è‚Œç´°èƒèˆ’å¼µæ”¾é¬†ï¼Œä¿ƒé€²æ–°é™³ä»£è¬ï¼Œå¹«åŠ©è¡€æ¶²å¾ªç’°ï¼Œæ”¹å–„èº«é«”å› è¡€æ¶²ä¸é †æ‰€é€ æˆçš„ç–²å‹ï¼Œä¹Ÿèƒ½æå‡ä¿è­·åŠ›ã€‚

å¦å¤–å®ƒçš„ç‰¹æ®ŠåŠŸèƒ½æœ‰å¤šé‡è¦ï¼Œä¸ç”¨å¤šèªªï¼

## **ageLOC R2 ä½¿ç”¨è€…å›é¥‹åˆ†äº«**

  *   *   *   * 

## **ageLOC R2** **é©åˆä»€éº¼æ¨£çš„äººä½¿ç”¨**

  * çˆ†è‚å·¥ç¨‹å¸«
  * å¸¸å¸¸ç†¬å¤œç™½å¤©ç²¾ç¥ä¸å¥½çš„äºº
  * æƒ³æå‡ç¡çœ å“è³ªçš„äºº
  * ã€Œåªå‰©ä¸€å¼µå˜´ã€çš„è€å…¬

è‡ªå·±åŠ å…¥è‡ªå·±è²·ï¼šğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡

> [æˆç‚º Nu Skin è‡ªç”¨æœƒå“¡è¶…ç°¡å–®ï¼Œå®Œå…¨å…è²»çœ‹åœ–å°±æœƒï¼](https://agelocked.com/%e6%88%90%e7%82%ba-nu-skin-%e8%87%aa%e7%94%a8%e6%9c%83%e5%93%a1%e8%b6%85%e7%b0%a1%e5%96%ae%ef%bc%8c%e5%ae%8c%e5%85%a8%e5%85%8d%e8%b2%bb%e7%9c%8b%e5%9c%96%e5%b0%b1%e6%9c%83%ef%bc%81/)

å›ºå®šè²·æ›´åˆ’ç®—ï¼šğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡

> [Nu Skin æœƒå“¡é€™æ¨£è²·æ›´åˆ’ç®—ï¼ä¸€æ­¥æ­¥æ•™ä½ åˆ©ç”¨ enJoy äº«å›è³¼è¨ˆç•«è¨‚è²¨ï¼ŒçœŸçš„ enJOYï¼](https://agelocked.com/nu-skin-%e6%9c%83%e5%93%a1%e9%80%99%e6%a8%a3%e8%b2%b7%e6%9b%b4%e5%88%92%e7%ae%97%ef%bc%81%e4%b8%80%e6%ad%a5%e6%ad%a5%e6%95%99%e4%bd%a0%e5%88%a9%e7%94%a8-enjoy-%e4%ba%ab%e5%9b%9e%e8%b3%bc%e8%a8%88/)

åƒè€ƒè³‡æ–™ï¼š  
01\. C K Lee, R G Klopp, R Weindruch, T A Prolla, 1999. [Gene expression profile of aging and its retardation by caloric restriction.](https://pubmed.ncbi.nlm.nih.gov/10464095/) _Science._ 285(5432):1390-3.  
02\. R Weindruch, T Kayo, C K Lee, T A Prolla, 2001. [Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice.](https://pubmed.ncbi.nlm.nih.gov/11238786/) _J Nutr._ 131(3):918S-923S.  
03\. T Kayo, D B Allison, R Weindruch, T A Prolla, 2001. [Influences of aging and caloric restriction on the transcriptional profile of skeletal muscle from rhesus monkeys.](https://pubmed.ncbi.nlm.nih.gov/11309484/) _PNAS._ 98(9):5093-8.  
04\. Richard Weindruch, Tsuyoshi Kayo, Cheol Koo Lee, Tomas A Prolla, 2002. [Gene expression profiling of aging using DNA microarrays. ](https://pubmed.ncbi.nlm.nih.gov/11718811/)_Mech Ageing Dev._ 123(2-3):177-93.  
05\. Tomas A Prolla, 2002. [DNA microarray analysis of the aging brain.](https://pubmed.ncbi.nlm.nih.gov/11923192/) _Chem Senses._ 27(3):299-306.  
06\. Cheol-Koo Lee, Thomas D Pugh, Roger G Klopp, Jode Edwards, David B Allison, Richard Weindruch, Tomas A Prolla, 2004. [The impact of alpha-lipoic acid, coenzyme Q10 and caloric restriction on life span and gene expression patterns in mice.](https://pubmed.ncbi.nlm.nih.gov/15059645/) _Free Radic Biol Med._ 36(8):1043-57.  
07\. Sang-Kyu Park , Tomas A Prolla, 2005. [Lessons learned from gene expression profile studies of aging and caloric restriction.](https://pubmed.ncbi.nlm.nih.gov/15619470/) _Ageing Res Rev._ 4(1):55-65.  
08\. Sang-Kyu Park, Tomas A Prolla, 2005. [Gene expression profiling studies of aging in cardiac and skeletal muscles.](https://pubmed.ncbi.nlm.nih.gov/15820189/) _Cardiovasc Res._ 66(2):205-12.  
09\. G C Kujoth, A Hiona, T D Pugh, S Someya, K Panzer, S E Wohlgemuth, T Hofer, A Y Seo, R Sullivan, W A Jobling, J D Morrow, H Van Remmen, J M Sedivy, T Yamasoba, M Tanokura, R Weindruch, C Leeuwenburgh, T A Prolla, 2005. [Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging.](https://pubmed.ncbi.nlm.nih.gov/16020738/) _Science._ 309(5733):481-4.  
10\. Gregory C Kujoth, Patrick C Bradshaw, Suraiya Haroon, Tomas A Prolla, 2007. [The role of mitochondrial DNA mutations in mammalian aging.](https://pubmed.ncbi.nlm.nih.gov/17319745/) _PLoS Genet._ 3(2):e24.  
11\. Gregory C Kujoth, Tomas A Prolla, 2008. [Evolving insight into the role of mitochondrial DNA mutations in aging.](https://pubmed.ncbi.nlm.nih.gov/18054193/) _Exp Gerontol._ 43(1):20-3.  
12\. Jamie L Barger, Tsuyoshi Kayo, James M Vann, Edward B Arias, Jelai Wang, Timothy A Hacker, Ying Wang, Daniel Raederstorff, Jason D Morrow, Christiaan Leeuwenburgh, David B Allison, Kurt W Saupe, Gregory D Cartee, Richard Weindruch, Tomas A Prolla, 2008. [A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice.](https://pubmed.ncbi.nlm.nih.gov/18523577/) _PLoS One._ 3(6):e2264.  
13\. Sang-Kyu Park, Grier P Page, Kyoungmi Kim, David B Allison, Mohsen Meydani, Richard Weindruch, Tomas A Prolla, 2008. [alpha- and gamma-Tocopherol prevent age-related transcriptional alterations in the heart and brain of mice.](https://pubmed.ncbi.nlm.nih.gov/18492827/) _J Nutr._ 138(6):1010-8.  
14\. Sang-Kyu Park, Kyoungmi Kim, Grier P Page, David B Allison, Richard Weindruch, Tomas A Prolla, 2009. [Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants.](https://pubmed.ncbi.nlm.nih.gov/19555370/) _Aging Cell._ 8(4):484-95.  
15\. Tomas A prolla, John M Denu, 2014. [NAD+ deficiency in age-related mitochondrial dysfunction.](https://pubmed.ncbi.nlm.nih.gov/24506863/) _Cell Metab._ 19(2):178-80.  
16\. Ning-Zhi Tan, Jamie L Barger, Yan Zhang, Scott B Ferguson, Zi-Mei Wu, Tomas A Prolla, Mark Bartlett, Jia-Shi Zhu, 2011. [The lifespan-extending effect of Cordyceps sinensis Cs-4 in normal mice and its molecular mechanisms](https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fasebj.25.1_supplement.599.1). FASEB.   
17\. Jie-Ying Yang, Yun-Zi Dong, Chun-Sheng Zhao, Zi-Mei Wu, Yan Zhang, Ning-Zhi Tan, Ji-Hong Lu, Mark Bartlett, Jia-Shi Zhu, 2011. [An ageLOC Vitality formula improves endurance exercise in aged mice and energy metabolism in muscle mitochondria](https://faseb.onlinelibrary.wiley.com/doi/10.1096/fasebj.25.1_supplement.1114.9). FASEB.  
18\. Jie-Ying Yang, Yun-Zi Dong, Chun-Sheng Zhao, Zi-Mei Wu, Yan Zhang, Ning-Zhi Tan, Ji-Hong Lu, Mark Bartlett, Jia-Shi Zhu, 2011. [ageLOC Vitality improves endurance exercise, exercise glucose metabolism and antioxidant capacity in an aging model](https://faseb.onlinelibrary.wiley.com/doi/10.1096/fasebj.25.1_supplement.1049.2). FASEB.  
19\. Zimei Wu, Yunzi Dong, Chunsheng Zhao, Yan Zhang, Ningzhi Tan, Jihong Lu, Jia-Shi Zhu, 2012. [ageLOC Vitality enhances sexual functions in normal and impotent models.](https://faseb.onlinelibrary.wiley.com/doi/10.1096/fasebj.26.1_supplement.1095.1) FASEB.  
20\. Ning-Zhi Tan, Jie-Ying Yang, Guang Yang, Jia-Shi Zhu, 2013. [ageLOC Vitality improves memory and learning ability in memory impairment models.](https://faseb.onlinelibrary.wiley.com/doi/10.1096/fasebj.27.1_supplement.661.4) FASEB.   
21\. Jia-Shi Zhu, Yan Zhang, Jieying Yang, Ningzhi Tan, Angela Mastaloudis, Chunsheng Zhao, 2010. [Antioxidant and Lifespan-Extension Activities of Cordyceps Sinensis CS-4 in Oxidative Stress and Aging Models.](https://www.nuskinantiagingscience.com/content/dam/ageloc/microsite/PDFs/Antioxidant%20and%20Lifespan%20Extension%20Activities%20of%20Cordyceps%20Sinensis%20in%20Oxidative%20Stress.pdf)  
22\. SM Wood, JL Barger, TA Prolla, R Weindruch, A Mastaloudis, SB Ferguson, 2010. [Transcriptional Biomarkers of Mitochondrial Aging and Modulation by Cordyceps-Sinensis CS-4.](https://www.nuskinantiagingscience.com/content/dam/ageloc/microsite/PDFs/Transcriptional%20Biomarkers%20of%20Mitochondrial%20Aging%20and%20Modulation%20by%20Cordyceps.pdf)  
23\. Steve Chen, Zhaoping Li, Robert Krochmal, Marlon Abrazado, Woosong Kim, Christopher B Cooper, 2010. [Effect of Cs-4Â® (_Cordyceps sinensis_) on Exercise Performance in Healthy Older Subjects: A Double-Blind, Placebo-Controlled Trial.](https://pubmed.ncbi.nlm.nih.gov/20804368/) _J Altern Complement Med._ 16(5):585-90.  
24\. A Mastaloudis, JL Barger, TA Prolla, R Weindruch, SB Ferguson, SM Wood, 2011. [A PCR-based screen to identify natural compounds with the ability to influence Nfr2-mediated transcriptional induction of detoxification/antioxidant genes.](https://www.nuskinantiagingscience.com/content/dam/ageloc/microsite/PDFs/A%20PCR-based%20screen%20to%20identify%20natural%20compounds%20with%20the%20ability%20to%20inf%20%20%20.pdf)  
25\. Mastaloudis A, Barger JL, Prolla TA, Weindruch R, Wood SM, 2012. [A unique blend of natural compounds opposes age-related changes in gene expression related to dysregulation of cellular detoxification and antioxidant protection.](https://www.nuskinantiagingscience.com/content/dam/Science/Science_articles_posters/R2%20Society%20for%20Free%20Radical%20Research%20International%20Poster%2c%20London%2c%20Mastaloudis%202012.pdf) Free Radical Biology and Medicine 53:S83.  
26\. Chi Chen, A-N Tony Kong, 2004. [Dietary chemopreventive compounds and ARE/EpRE signaling.](https://pubmed.ncbi.nlm.nih.gov/15182853/) _Free Radic Biol Med._ 36(12):1505-16.  
27\. Angela Mastaloudis, Steven M Wood, 2012. [Age-related changes in cellular protection, purification, and inflammationrelated gene expression: role of dietary phytonutrients.](https://pubmed.ncbi.nlm.nih.gov/22758643/) _Ann N Y Acad Sci._ 1259:112-20.  
å°ˆåˆ©ï¼š  
01\. US9795645B2:[Oral formulations for counteracting effects of aging](https://patentimages.storage.googleapis.com/a5/6c/b0/9f395a9f1bd196/US9795645.pdf)  
02\. WO2012174484A2:[Identifying markers of caloric restriction and caloric restriction mimetics.](https://patents.google.com/patent/WO2012174484A2/en)  
03\. US20130071369A1:[Oral Formulations For Promoting Cellular Purification.](https://patents.google.com/patent/US20130071369A1/fr)

å–œæ­¡æˆ‘å¯«çš„å…§å®¹å—?  
è«‹é»é¸åŠ å…¥å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤å°ˆå€å‘Šè¨´æˆ‘ä½ çš„æ„Ÿæƒ³èˆ‡è©•è«– ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡  

[ å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤æœƒå“¡å°ˆå€ ](https://lin.ee/jgugMvX)

æƒ³ç¬¬ä¸€æ‰‹æ¥æ”¶ç”¢å“å¿«è¨Šèˆ‡ç§‘å­¸æ–°çŸ¥å—ï¼Ÿ  
æœ‰æ­é…å¦‚æ–°ä¿å¥å“å•é¡Œæƒ³å•å—ï¼Ÿ  
è«‹é»é¸åŠ å…¥å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤å°ˆå€åšè«®è©¢ ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡  

[ å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤æœƒå“¡å°ˆå€ ](https://lin.ee/jgugMvX)